JULIE BAILEY: Open Payments
NPI 1457879314 · WINDHAM, ME. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$335 in 16 payments from 10 companies in 2025. Trend: 2023 $126 · 2024 $690 · 2025 $335
Food & beverage: $335
| Company | Payments | Amount |
|---|---|---|
| Axsome Therapeutics, Inc. | 3 | $72 |
| Phathom Pharmaceuticals, Inc. | 3 | $57 |
| ABBVIE INC. | 2 | $46 |
| AstraZeneca Pharmaceuticals LP | 2 | $33 |
| PFIZER INC. | 1 | $29 |
| Amgen Inc. | 1 | $22 |
| Sumitomo Pharma America, Inc. | 1 | $21 |
| Verona Pharma, Inc. | 1 | $21 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $19 |
| Exact Sciences Corporation | 1 | $15 |
Products named: Auvelity, VOQUEZNA, BREZTRI, UBRELVY, ELIQUIS, EVENITY, GEMTESA, Ohtuvayre.
Industry payments across ME — which companies pay providers there.
